DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Anti-CD80 Antibody - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Anti-CD80 Antibody - Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD80 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Anti-CD80 Antibody - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Anti-CD80 Antibody - Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Anti-CD80 Antibody Pipeline Products in Clinical Stages

6. Anti-CD80 Antibody Pipeline Products in Non-clinical Stages

7. Therapeutic Assessment: Active Products

8. Inactive Pipeline Products

Companies Mentioned

Momenta Pharmaceuticals MacroGenics KAHR Medica momenta Pharmaceuticals Hunan Zhaotai Yongren Biotech

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/7sp9qp/anticd80?w=4.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005507/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD: EUROPE ASIA PACIFIC NORTH AMERICA SOUTH AMERICA AFRICA MIDDLE EAST

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/23/2018 10:31 AM/DISC: 08/23/2018 10:31 AM

http://www.businesswire.com/news/home/20180823005507/en